The objectives of the Planning and Evaluation Core (PEC) are to facilitate strategic planning, monitoring, and evaluation of the Partnership activities designed to close the gap in information needed about precision medicine, and ultimately reduce Hispanic/Latino (H/L) cancer health disparities. An Internal Advisory Committee (IAC) and an external advisory board, the Program Steering Committee (PSC), provide guidance and recommendations. In addition to the IAC and PSC, the PEC consults with Dr. Caprice Knapp, an evaluation and process expert from Pennsylvania State University. She is external to both PHSU and MCC and can provide objective and formal systematic evaluations. The PEC team will also conduct systematic evaluations of all Partnership activities and projects. These evaluations will contribute toward identifying the strengths and weaknesses of the Partnership and its individual components, as well as to provide data to the Administrative Core (AC) in guiding the direction of the Partnership. This will be achieved through the following Specific Aims: (1) To collect and evaluate results on the progress of all Partnership components with the goal to initiate, terminate, or modify new and on-going initiatives using a Continuous Quality Improvement (CQI) approach to achieve the Partnership goals and objectives. This will be achieved through on-going collection and evaluation of process and outcome data using a web-based system; (2) To facilitate and evaluate communication between the senior leadership of both institutions regarding progress and future directions of the Partnership; and (3) To maintain and grow a pipeline of new initiatives and competitive research projects.
Bonilla-Valentín, Fernando Javier; Cerra, Javier; Cáceres-Perkins, William et al. (2018) Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity. Cancer Control 25:1073274817744448 |
Pérez-Morales, Jaileene; Núñez-Marrero, Angel; Santiago-Cardona, Pedro G (2018) Immunohistochemical Detection of Retinoblastoma Protein Phosphorylation in Human Tumor Samples. Methods Mol Biol 1726:77-84 |
Dutil, Julie; Godoy, Lenin; Rivera-Lugo, Rafael et al. (2018) No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis. Genet Test Mol Biomarkers 22:85-89 |
Reverón, Dayana; López, Christian; Gutiérrez, Sylvia et al. (2018) Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma. Cancer Genomics Proteomics 15:265-271 |
Gonçalves, Vânia; Hudson, Janella; Canavarro, Maria Cristina et al. (2018) Childbearing across borders: Fertility and parenthood attitudes and decisions among breast cancer survivors in USA and Portugal. Breast 40:16-22 |
Colón-Caraballo, Mariano; Torres-Reverón, Annelyn; Soto-Vargas, John Lee et al. (2018) Effects of histone methyltransferase inhibition in endometriosis. Biol Reprod 99:293-307 |
Rodríguez-López, Joshua L; Toro-Bahamonde, Alia M; Santiago-Méndez, Roberto J et al. (2018) An Unusual Case of Colorectal Adenocarcinoma Presenting as an Anterior Mediastinal Mass. Clin Colorectal Cancer 17:e115-e119 |
Lee, Miyoung; Gudas, Lorraine J; Saavedra, Harold I (2018) Detection of E2F-DNA Complexes Using Chromatin Immunoprecipitation Assays. Methods Mol Biol 1726:143-151 |
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242 |
Jiménez, Julio; Ramos, Axel; Ramos-Rivera, Francisco E et al. (2018) Community Engagement for Identifying Cancer Education Needs in Puerto Rico. J Cancer Educ 33:12-20 |
Showing the most recent 10 out of 72 publications